Black Rock Inc. Macrogenics Inc Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Macrogenics Inc stock. As of the latest transaction made, Black Rock Inc. holds 5,401,728 shares of MGNX stock, worth $8.32 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,401,728

Previous 5,696,194 5.17%

Holding current value

$8.32 Million

Previous $83.8 Million 72.62%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$3.31 - $18.51 $974,682 - $5.45 Million	-294,466 Reduced 5.17%	5,401,728 $23 Million
Q1 2024 May 10, 2024	SELL	$9.77 - $21.47 $4.34 Million - $9.54 Million	-444,155 Reduced 7.23%	5,696,194 $83.8 Million
Q4 2023 Feb 13, 2024	BUY	$4.48 - $10.11 $467,349 - $1.05 Million	104,319 Added 1.73%	6,140,349 $59.1 Million
Q3 2023 Nov 13, 2023	BUY	$4.48 - $6.19 $177,381 - $245,086	39,594 Added 0.66%	6,036,030 $28.1 Million
Q2 2023 Aug 11, 2023	SELL	$4.62 - $7.54 $1,593 - $2,601	-345 Reduced 0.01%	5,996,436 $32.1 Million

Q1 2023 May 12, 2023	BUY	$4.82 - $7.24 $30,250 - $45,438	6,276 Added 0.1%	5,996,781 $43 Million
Q4 2022 Feb 13, 2023	BUY	$3.34 - $6.98 $893,650 - $1.87 Million	267,560 Added 4.68%	5,990,505 $40.2 Million
Q3 2022 Nov 14, 2022	BUY	$3.01 - $5.22 $1.12 Million - $1.94 Million	372,141 Added 6.95%	5,722,945 $19.8 Million
Q2 2022 Aug 12, 2022	BUY	$2.25 - $9.99 $413,784 - $1.84 Million	183,904 Added 3.56%	5,350,804 $15.8 Million
Q1 2022 May 12, 2022	SELL	$8.12 - $16.9 $226,815 - $472,067	-27,933 Reduced 0.54%	5,166,900 $45.5 Million
Q4 2021 Feb 10, 2022	SELL	$15.91 - $21.88 $2.67 Million - $3.68 Million	-167,973 Reduced 3.13%	5,194,833 $83.4 Million
Q3 2021 Nov 09, 2021	SELL	$19.74 - $28.7 $4.07 Million - $5.92 Million	-206,391 Reduced 3.71%	5,362,806 $112 Million
Q2 2021 Aug 11, 2021	BUY	$20.49 - $35.63 $114 Million - $198 Million	5,569,197 New	5,569,197 $150 Million

Others Institutions Holding MGNX

# of Institutions

111

Shares Held

50M

Call Options Held

65.5K

Put Options Held

93.9K

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $94.6M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account